Proteome Share News (PRM)
PRM Share
PRM Share
PRM Share
PRM Share
PRM
PRM Share
PRM Level 2
PRM Live
PRM Broker
PRM Directors
PRM Financial
PRM
PRM Short
PRM
Last checked at -
Thu, 09th Aug 2018 14:50
LONDON (Alliance News) - Proteome Sciences said Thursday that Vulpes Life Sciences Fund purchased 1.4 million shares in the company on Tuesday at 3.50 pence each.
Vulpes now has a 19.6% holding in the company, equivalent to an interest in 57.8 million shares.
Martin Diggle, director of both Vulpes Investment Management and Proteome, now also holds a 19.6% interest in Proteome.
Shares in Proteome were down 2.5% at 3.558 pence each on Thursday.
LONDON (Alliance News) - Hargreaves Services PLC said Friday that David Morgan has decided to step down as chairman and will be succeeded by Roger McDowell.Morgan, who has served as a since
Read moreLONDON (Alliance News) - Proteome Sciences PLC on Tuesday appointed Chief Commercial Officer Richard Dennis to the board of directors.Dennis joined Proteome in April last year, having as an
Read moreLONDON (Alliance News) - Life sciences firm Proteome Sciences PLC said Tuesday its annual loss narrowed in 2017 on higher revenue and lower costs, as it looks to focus growth on its biomarker loss
Read more
(ShareCast News) - Proteome Sciences provided a trading update for the 12 months to 31 December on Thursday, saying that after a strong first half, progress continued throughout the rest of the year with results in line with expectations. The AIM-traded firm said buoyed by robust sales of its TMT re
Read more(ShareCast News) - After offering the shares at a highly discounted price before getting shareholder approval, Proteome Sciences has raised £3.3m through a placing and subscription of new shares to accelerate its strategy and meet client demand. The AIM-listed company issued the shares at 5p, a 45%
Read more(ShareCast News) - Proteome Sciences released its unaudited interim results for the six months to 30 June on Thursday, with revenues to 30 June increasing 32% to £1.12m. The AIM-traded company said revenue from licences, sales and services increased 44% to £1.08m during the period, while TMT reagent
Read more
Last checked at